Using HIV Transmission Networks to Investigate Community Effects in HIV Prevention Trials

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Wertheim, Joel O ^a   Kosakovsky Pond, Sergei L ^b   Little, Susan J ^b   De Gruttola, Victor ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PLACEBO;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL STUDY; COMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MALE; PRE EXPOSURE PROPHYLAXIS; PROPHYLAXIS; SEXUAL BEHAVIOR; SEXUALITY; SIMULATION; STATISTICAL ANALYSIS; UNITED STATES; VIRUS TRANSMISSION; CLINICAL TRIAL (TOPIC); COMPUTER SIMULATION; DISEASE TRANSMISSION; PATHOGENICITY; STATISTICS; VIROLOGY;

CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; HIV; HIV INFECTIONS; HUMANS; MALE;

EID: 84860550851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027775     Document Type: Article

References (24)

1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al.(2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2: e298.
2. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al.(2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369: 643-656.
3. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al.(2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657-666.
4. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al.(2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168-1174.
5. Baeten JM, Celum C, (2011) Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: the Partners PrEP Study. 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011). Rome,Italy.Abstract MOAX0106.
6. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, et al.(2010) Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N Engl J Med 363: 2587-2599.
7. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al.(2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220.
8. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, et al.(2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375: 2092-2098.
9. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
10. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, et al.(2001) Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 17: 901-910.
11. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al.(2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342: 921-929.
12. Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, et al.(2004) Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 351: 217-228.
13. Manhart LE, Holmes KK, (2005) Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J Infect Dis 191 (Suppl 1): S7-24.
14. Bon I, Ciccozzi M, Zehender G, Biagetti C, Verrucchi G, et al.(2010) HIV-1 subtype C transmission network: the phylogenetic reconstruction strongly supports the epidemiological data. J Clin Virol 48: 212-214.
15. Leitner T, Escanilla D, Franzen C, Uhlen M, Albert J, (1996) Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. Proc Natl Acad Sci U S A 93: 10864-10869.
16. Lemey P, Van Dooren S, Van Laethem K, Schrooten Y, Derdelinckx I, et al.(2005) Molecular testing of multiple HIV-1 transmissions in a criminal case. AIDS 19: 1649-1658.
17. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ, (2008) Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 5: e50.
18. Metzker ML, Mindell DP, Liu XM, Ptak RG, Gibbs RA, et al.(2002) Molecular evidence of HIV-1 transmission in a criminal case. Proc Natl Acad Sci U S A 99: 14292-14297.
19. Paraskevis D, Magiorkinis E, Magiorkinis G, Kiosses VG, Lemey P, et al.(2004) Phylogenetic reconstruction of a known HIV-1 CRF04_cpx transmission network using maximum likelihood and Bayesian methods. J Mol Evol 59: 709-717.
20. Scaduto DI, Brown JM, Haaland WC, Zwickl DJ, Hillis DM, et al.(2010) Source identification in two criminal cases using phylogenetic analysis of HIV-1 DNA sequences. Proc Natl Acad Sci U S A 107: 21242-21247.
21. Hughes GJ, Fearnhill E, Dunn D, Lycett SJ, Rambaut A, et al.(2009) Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog 5: e1000590.
22. Smith DM, May SJ, Tweeten S, Drumright L, Pacold ME, et al.(2009) A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS 23: 225-232.
23. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, et al.(2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17: 1871-1879.
24. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al.(2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552-7557.